Overview A Study of Lu AG06466 for the Treatment of Spasticity in Participants With Multiple Sclerosis Status: Recruiting Trial end date: 2022-10-31 Target enrollment: Participant gender: Summary The main purpose of this study is to investigate Lu AG06466 as a treatment for spasticity in participants with multiple sclerosis (MS). Phase: Phase 1 Details Lead Sponsor: H. Lundbeck A/S